Effect of Patient Navigation on Colonoscopy Completion Screening Rate for Colorectal Cancer.
NCT ID: NCT06684067
Last Updated: 2024-11-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
52 participants
INTERVENTIONAL
2020-02-03
2022-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Are colonoscopy completion rates in colorectal cancer screening increased in navigated (intervention arm) compared with non-navigated (control arm) participants?
Is mental well-being, as measured by HADs and GHQ12 scores, better in the intervention arm compared with the control arm?
Participants in the intervention arm will receive:
* standard clinic instructions for the colonoscopy
* phone calls from the patient navigator to discuss the purpose, preparation, and additional information regarding the colonoscopy procedure
* a webpage QR code consist of information on visual image on colonoscopy preparation and procedures, layout and map guidance to navigate in the hospital
* a direct line for phone calls to patient navigators for further guidance on overcoming barriers
Participants in the control arm will only receive:
* standard clinic instructions for the colonoscopy
* one phone call from the patient navigator to discuss the colonoscopy procedure
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Decision-aid Video on Colorectal Cancer Screening
NCT04692987
Personalized Screening Plans to Increase Colorectal Cancer Screening in Healthy Participants
NCT00617071
Patient Navigation for Colorectal Cancer Screening
NCT06401174
Quantitative Versus Qualitative Fecal Immunochemical Tests (FIT) to Prioritize Urgency of Colonoscopy Referral
NCT02037646
Effect of an Advanced Notification Letter on Screening Colonoscopy Participation
NCT02188927
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient navigation
Participants in the intervention arm will undergo a patient navigation process
Patient navigation
Participants will receive online educational material, hospital site navigation guidance and direct contact with the patient navigator, in addition to standard instructions on the colonoscopy procedure.
No navigation
Participants in the control arm will receive standard instructions and not undergo the patient navigation process.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patient navigation
Participants will receive online educational material, hospital site navigation guidance and direct contact with the patient navigator, in addition to standard instructions on the colonoscopy procedure.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* More than 50 years of age
* Capacity for informed consent
* IFOBT positive
Exclusion Criteria
* Previous CRC screening
* Symptomatic
50 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Health, Malaysia
OTHER_GOV
University of Malaya
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
April C Roslani, Master of Surgery
Role: PRINCIPAL_INVESTIGATOR
Universiti Malaya
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine, Universiti Malaya
Kuala Lumpur, Kuala Lumpur, Malaysia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MREC ID No: 202057-8603
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.